Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of CBX-12 in Pediatric Patients With Relapsed or Refractory Solid Tumors

NCT07830667 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT07830667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07830667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of CBX-12 in Pediatric Patients With Relapsed or Refractory Solid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
May 7, 2027
Completion date
June 30, 2033
Enrollment
79 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent childhood ewing sarcoma, recurrent childhood malignant solid neoplasm, recurrent childhood rhabdomyosarcoma, recurrent ewing sarcoma, recurrent extracranial malignant solid neoplasm, recurrent rhabdomyosarcoma, refractory childhood ewing sarcoma, refractory childhood malignant solid neoplasm, refractory childhood rhabdomyosarcoma, refractory ewing sarcoma, refractory extracranial malignant solid neoplasm, refractory rhabdomyosarcoma